Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial
Por:
Postel-Vinay S, Coves J, Texier M, Aldea M, Gazzah A, Domine M, Planchard D, De Las Peñas R, Gonzalez M, Viteri S, Perez J, Ortega A, Moran T, Camps C, Lopez-Martin A, Provencio M, Soria J, Besse B, Massuti B, Rosell R
Publicada:
14 dic 2023
Ahead of Print:
1 dic 2023
Resumen:
|